Esmaeilzadeh, MajidFonouni, HamidrezaGolriz, MohammadMajlesara, AliKuttymuratov, GaniBergmann, FrankJarahian, ParvinKhazaeipour, ZahraFaridar, AlirezaTahmasbi, MorvaLongerich, ThomasGebhard, Marta M.Mehrabi, Arianeb2018-06-062018-06-062016Majid Esmaeilzadeh, Hamidreza Fonouni, Mohammad Golriz, Ali Majlesara, Gani Kuttymuratov, Frank Bergmann, Parvin Jarahian, Zahra Khazaeipour, Alireza Faridar, Morva Tahmasbi Rad, Thomas Longerich, Martha M. Gebhard and Arianeb Mehrabi. (2016) Evaluation of the modified HTK solution in pancreas transplantationdAn experimental model. Asian Journal of Surgery. Volume 39. Issue 2. Pages 66-73dx.doi.org/10.1016/j.asjsur.2015.03.017http://nur.nu.edu.kz/handle/123456789/3321One of the great challenges in pancreas transplantation is the ischemia reperfusion injury. It is mentioned that free oxygen and/or nitrogen radicals play a prominent role in this phase. To minimize this problem, a modified histidineetryptophan eketoglutarate (HTK) solution that contains modified antioxidants has been developed. Our aim was to evaluate this solution in improving the viability of the pancreas in comparison with standard HTK and University of Wisconsin (UW) solutions in a porcine model of pancreas transplantation.enAttribution-NonCommercial-NoDerivs 3.0 United Stateshistidine tryptophan ketoglutarateischemia reperfusion injurypancreas transplantationUniversity of WisconsinArticle